Pharma company CSL Behring, whose roots go back over a century, has debuted its first-ever TV commercial: a :60 spot for Hizentra, a 15-year-old treatment for the rare disease of primary ...
Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...
SUMMIT, N.J., July 9, 2024 /PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), today announced that it has commenced shipping its differentiated portfolio of influenza vaccines. This year, the ...